Published in Medical Verdicts and Law Weekly, October 1st, 2009
"The presentations at the ECCO/ESMO conference will continue to build on our large body of data in unresectable liver cancer and advanced kidney cancer where Nexavar has a proven track record," said Dimitris Voliotis, Vice President, Global...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly